Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02135575
Other study ID # CWS-WP2CV
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2014
Est. completion date July 2017

Study information

Verified date August 2018
Source University of Copenhagen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The hypothesis of the present study is that physical training can oppose detrimental changes in cardiovascular and metabolic health associated with estrogen loss after menopause.


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date July 2017
Est. primary completion date July 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 45 Years to 57 Years
Eligibility Inclusion Criteria:

- Premenopausal (45-53 years) OR postmenopausal 50-57 years

- BMI> 18.5 and <30

- Sedentary (no regular physical activity the last 2 years)

- Plasma measurements

- Premenopausal: estradiol> 0.20 nmol/l, Follicle stimulating hormone < 22 IU/l and progesterone >2.5 nmol/l

- Postmenopausal: estradiol < 0.20 nmol/l, Follicle stimulating hormone > 22 IU/l and progesterone 0.3-2.5 nmol/l

Exclusion Criteria:

- Smoking

- Excessive alcohol intake

- Regular medication including hormone replacement treatment

- Chronic disease

Study Design


Intervention

Behavioral:
Spinning
After the baseline studies the pre and postmenopausal women will be randomized to spinning training groups and the intervention will last for 3 months. The spinning group will spin three times per week under guidance of a trained instructor. The training is heart rate monitored.

Locations

Country Name City State
Denmark University of Copenhagen Copenhagen

Sponsors (3)

Lead Sponsor Collaborator
University of Copenhagen Glostrup University Hospital, Copenhagen, Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Anthropometry Dual x-ray absorptiometry, height, weight, waist and hip circumference Baseline comparison and changes from baseline to 3 months
Other Activity measure Activity measure for one week by accelerometer Baseline comparison and changes from baseline to 3 months
Primary Leg vascular function Measurements of leg blood flow by ultrasound doppler during exercise and during femoral arterial infusion of vasodilators Baseline comparison and changes from baseline to 3 months
Primary Cardiac structure and function Magnetic resonance imaging and transthoracic echocardiography Baseline comparison and changes from baseline to 3 months
Primary Platelet function Platelet aggregation assay of whole blood and platelet rich plasma Baseline comparison and changes from baseline to 3 months
Secondary Expression of proteins in muscle samples Western Blot analysis of proteins of relevance for vascular function and metabolism Baseline comparison and changes from baseline to 3 months
Secondary Maximal aerobic effect Maximal oxygen uptake during an incremental cycle ergometry test with gas analysis Baseline comparison and changes from baseline to 3 months
Secondary Genomic profile in blood samples Genomic analysis of parameters for vascular and metabolic health Baseline comparison and changes from baseline to 3 months
Secondary Insulin sensitivity and glycaemic control Fasting plasma glucose analysis and oral glucose tolerance test Baseline comparison and changes from baseline to 3 months
Secondary Arterial blood pressure Baseline comparison and changes from baseline to 3 months
Secondary Gene expression of proteins in muscle samples Gene analysis of relevance for vascular and metabolic function Baseline comparison and changes from baseline to 3 months
Secondary Health related parameters in blood Plasma lipid status and other variables related to vascular health Baseline comparison and changes from baseline to 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06211361 - Cardiac Rehabilitation Program in Patients With Cardiovascular Disease N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)